NSF-MR-Contrastmedia - Introduction

P. Marckmann, Henrik S. Thomsen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    7 Citationer (Scopus)

    Abstract

    Until recently it was believed that extracellular gadolinium based contrast agents (Gd-CA) were safe for both the kidneys and all other organs within the dose range up to 0.3 mmol/kg body weight. However, in 2006, it was demonstrated that some Gd-CA may trig the development of nephrogenic systemic fibrosis, a generalized fibrotic disorder, in renal failure patients. This sub-section of European Journal of Radiology covers the current knowledge about NSF from many aspects. The prevention of NSF must be given high priority, but it should not lead to a denial of a well-justified, enhanced MRI examination with a stable agent. (C) 2008 Elsevier Ireland Ltd. All rights reserved
    Udgivelsesdato: 2008/5
    OriginalsprogEngelsk
    TidsskriftEuropean Journal of Radiography
    Vol/bind66
    Udgave nummer2
    Sider (fra-til)153-159
    Antal sider6
    ISSN1756-1175
    StatusUdgivet - 2008

    Bibliografisk note

    Times Cited: 0Editorial MaterialEnglishThomsen, H. SCopenhagen Univ Hosp, Dept Diagnost Radiol 54E2, Herlev Ringvej 75, DK-2730 Herlev, DenmarkCited References Count: 20304WXELSEVIER IRELAND LTDELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELANDCLARE

    Citationsformater